Glass House Brands (GLAS) Change in Inventory (2020 - 2026)
Glass House Brands' (GLAS) quarterly Change in Inventory came in at -$5.3 million in Q1 2026, down 271.33% year-on-year from $3.1 million in Q1 2025, and down 131.05% on a QoQ basis from $17.1 million in Q4 2025.
Glass House Brands (GLAS) Change in Inventory (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Change in Inventory data on file, last reported at -$5.3 million in Q1 2026.
- On a quarterly basis, Change in Inventory fell 271.33% year-over-year to -$5.3 million in Q1 2026; TTM through Mar 2026 was $8.1 million, a 27.42% increase from a year earlier, with the FY2025 full-year figure at $12.0 million, up 121.27% from the prior year.
- Change in Inventory for Q1 2026 stood at -$5.3 million, down from $17.1 million in the prior quarter.
- Over the last five years, Change in Inventory for GLAS reached as high as $17.1 million in Q4 2025 and fell as low as -$5.3 million in Q1 2026.
- Historically, Change in Inventory has averaged $1.1 million across 5 years, with a median of $293000.0 in 2025.
- Across the five-year window, Change in Inventory plunged 331.66% in 2023 and soared 828.91% in 2024, its largest moves.
- Year by year, Change in Inventory stood at $922000.0 in 2022, then tumbled by 298.49% to -$1.8 million in 2023, then surged by 828.91% to $13.3 million in 2024, then grew by 28.18% to $17.1 million in 2025, then plunged by 131.05% to -$5.3 million in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were -$5.3 million in Q1 2026, $17.1 million in Q4 2025, and $293000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 40.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | -5.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.31 Mn |
| Mar 31, 2026 | -5.31 Mn |
| Dec 31, 2025 | 17.10 Mn |
| Dec 31, 2025 | 17.10 Mn |
| Sep 30, 2025 | 293,000.00 |
| Sep 30, 2025 | 293,000.00 |
| Jun 30, 2025 | -3.99 Mn |
| Jun 30, 2025 | -3.99 Mn |
| Mar 31, 2025 | -1.43 Mn |
| Mar 31, 2025 | -1.43 Mn |
| Dec 31, 2024 | 13.34 Mn |
| Dec 31, 2024 | 13.34 Mn |
| Sep 30, 2024 | -2.27 Mn |
| Sep 30, 2024 | -2.27 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Mar 31, 2024 | -2.37 Mn |
| Mar 31, 2024 | -2.37 Mn |
| Dec 31, 2023 | -1.83 Mn |
| Dec 31, 2023 | -1.83 Mn |